TY  - CONF

T1  - Safety of Amlitelimab in a Phase 2a Clinical Trial of Patients With Moderate-to-Severe Atopic Dermatitis

JO  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

PY  - 2023/01/01

AU  - Weidinger S

AU  - Cork M

AU  - Reich A

AU  - Bieber T

AU  - Gilbert S

AU  - Quaratino S

AU  - Wilson R

AU  - Porter-Brown B

ED  - 

VL  - 89

IS  - 3

SP  - AB221

EP  - AB221

Y2  - 2024/12/22

ER  -